title: Early onset proteinuria after renal transplantation: a marker for allograft dysfunction.
abstract: The objective of this study was to determine whether early proteinuria after renal transplantation affected long-term allograft survival. The 130 patients included 105 men and 25 women of overall mean age, 29.6 +/- 9.6 years. There were 105 living related and, 25 cadaveric donor transplants. Proteinuria was defined as a level in of more than 300 mg/d. Donor and recipient age at transplantation, duration of pretransplant dialysis, donor type (living related or cadaveric), the presence of delayed graft function or acute rejection, panel-reactive antibodies, the number of human leukocyte antigen mismatches, and the systolic blood pressure level were retrospectively recorded for the study subjects. Cox regression analysis was used to determine the effects of proteinuria on allograft survival. Patients with proteinuria demonstrated significantly lower graft survival rates than did those without proteinuria (54.17% vs 82.62%, respectively; P<.002). Proteinuria at the third month after transplantation (P<.004, odds ratio [OR]=3.26, confidence interval [CI]=1.46 to 7.29), donor age (P<.001, OR=1.06, CI=1.02 to 109), and panel-reactive antibodies (P<.041, OR=1.06, CI=1.00 to 1.12) were significantly associated with decreased allograft survival. Early proteinuria after renal transplantation was indicative of a high risk for allograft dysfunction. A reduction of proteinuria may be associated with improved graft survival.
authors.affiliation: Department of Nephrology, Baskent University Hospital, Ankara, Turkey. avsinibis@yahoo.com
authors.forename: A
authors.initials: A
authors.lastname: Ibis
authors.forename: A
authors.initials: A
authors.lastname: Altunoglu
authors.forename: A
authors.initials: A
authors.lastname: Akgül
authors.forename: C A
authors.initials: CA
authors.lastname: Usluogullari
authors.forename: Z
authors.initials: Z
authors.lastname: Arat
authors.forename: F N
authors.initials: FN
authors.lastname: Ozdemir
authors.forename: M
authors.initials: M
authors.lastname: Haberal
mesh_terms: D000328:Adult; D002102:Cadaver; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D019520:Living Donors; D008297:Male; D011183:Postoperative Complications / Q000652:urine; D011507:Proteinuria / Q000175:diagnosis*; D013997:Time Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000473:pathology*